Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia
暂无分享,去创建一个
O. Arancio | G. Thatcher | Jia Luo | S. Piyankarage | L. VandeVrede | D. R. Pepperberg | Zhihui Qin | E. Tavassoli | Lan Yue | Sue H. Lee | Rezene T. Asghodom | Mauro Fa’ | Manel Ben Aissa